Thomas J. Gunderson - 15 Jun 2026 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Jun 2026, 16:15:04 UTC
Prior SEC filing
21 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: /s/ Gerardo Hernandez, Attorney-in-Fact

Key filing fact

Thomas J. Gunderson filed Form 4 for TransMedics Group, Inc. (TMDX) on 17 Jun 2026.

Key facts

  • This page summarizes Thomas J. Gunderson's Form 4 filing for TransMedics Group, Inc. (TMDX).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 17 Jun 2026, 16:15.

Change

  • Previous filing in this sequence was filed on 21 May 2026.
  • Current net transaction value: -$722,377.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001708144 Primary reporting owner

Gunderson Thomas J.

Relationship
Director
Address
C/O TRANSMEDICS GROUP, INC., 200 MINUTEMAN ROAD, ANDOVER
Signature
By: /s/ Gerardo Hernandez, Attorney-in-Fact
Signature date
17 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TMDX transaction

Common Stock

Options Exercise

Transaction value
Shares
+19,285
Change %
+276%
Price
$2.21*
Shares after
26,266
Date
15 Jun 2026
Ownership
Direct
TMDX transaction

Common Stock

Sale

Transaction value
$722,377
Shares
-9,624
Change %
-37%
Price
$75.06
Shares after
16,642
Date
15 Jun 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TMDX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-19,285
Change %
-100%
Price
$0.000000*
Shares after
0
Date
15 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
19,285
Exercise price
$2.21
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares were sold to cover the exercise price and applicable tax withholding obligations in connection with the exercise of the stock options.

Footnote F2

The stock options were granted on August 1, 2016 and are fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .